Exact Mass: 416.0532

Exact Mass Matches: 416.0532

Found 22 metabolites which its exact mass value is equals to given mass value 416.0532, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

   

p-Hydroxymethoxybenzobijuglone

p-Hydroxymethoxybenzobijuglone

C23H12O8 (416.0532)


   

(+)-(1R,3R)-palmarumycin BG4

(+)-(1R,3R)-palmarumycin BG4

C20H16O8S (416.0566)


   

CAY10597

5-chloro-1-[(2-fluorophenyl)methyl]-2,2,5-trioxo-spiro[3H-indole-3,3-pyrrolidine-1(2H)-acetic acid

C20H14ClFN2O5 (416.0575)


   
   
   

5-Fluoro Risperidone

5-Fluoro Risperidone

C17H10F6N4S (416.053)


   

7-(6-bromohexoxy)-5-hydroxy-2-phenylchromen-4-one

7-(6-bromohexoxy)-5-hydroxy-2-phenylchromen-4-one

C21H21BrO4 (416.0623)


   
   

6-[[4-(2,5-Dihydro-2,5-Dioxo-1H-Pyrrol-1-Yl)Phenyl]Amino]-2-Naphthalenesulfonicacid Sodium Salt(1:1)

6-[[4-(2,5-Dihydro-2,5-Dioxo-1H-Pyrrol-1-Yl)Phenyl]Amino]-2-Naphthalenesulfonicacid Sodium Salt(1:1)

C20H13N2NaO5S (416.0443)


   
   

2,7,8-triamino-4-(3-bromo-4,5-dimethoxyphenyl)-4H-chromene-3-carbonitrile

2,7,8-triamino-4-(3-bromo-4,5-dimethoxyphenyl)-4H-chromene-3-carbonitrile

C18H17BrN4O3 (416.0484)


   
   

Crolibulin

Crolibulin

C18H17BrN4O3 (416.0484)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent

   

(2S)-3-(4-chloro-3-fluorophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide

(2S)-3-(4-chloro-3-fluorophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide

C18H13ClF4N2O3 (416.0551)


   

Carbenicillin potassium

Carbenicillin potassium

C17H17KN2O6S (416.0444)


   

2-[[3-(4-methylphenyl)-4-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]thio]-N-(2-thiazolyl)acetamide

2-[[3-(4-methylphenyl)-4-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]thio]-N-(2-thiazolyl)acetamide

C18H16N4O2S3 (416.0435)


   

5-Hydroxy-desmethylanthrotainin

5-Hydroxy-desmethylanthrotainin

C19H14NO10- (416.0618)


   

4-[[2-[(2E)-2-[(Z)-2-chloro-3-(4-nitrophenyl)prop-2-enylidene]hydrazinyl]-2-oxoacetyl]amino]benzoic acid

4-[[2-[(2E)-2-[(Z)-2-chloro-3-(4-nitrophenyl)prop-2-enylidene]hydrazinyl]-2-oxoacetyl]amino]benzoic acid

C18H13ClN4O6 (416.0524)


   

2-[(3E)-3-[(5Z)-5-[(6-bromo-1H-indol-3-yl)methylidene]-3,6-dioxopiperazin-2-ylidene]propyl]guanidine

2-[(3E)-3-[(5Z)-5-[(6-bromo-1H-indol-3-yl)methylidene]-3,6-dioxopiperazin-2-ylidene]propyl]guanidine

C17H17BrN6O2 (416.0596)


   
   

BAY-1797

BAY-1797

C20H17ClN2O4S (416.0598)


BAY-1797 is a potent, orally active, and selective P2X4 antagonist, with an IC50 of 211 nM against human P2X4. BAY-1797 displays no or very weak activity on the other P2X ion channels. BAY-1797 shows anti-nociceptive and anti-inflammatory effects[1].